Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots bought 5 shares of the business’s stock in a transaction on Monday, August 10th. The stock was purchased at an average price of GBX 3,292 per share, with a total value of £164.60.
Steve Foots also recently made the following trade(s):
- On Friday, July 10th, Steve Foots purchased 5 shares of Croda International stock. The shares were purchased at an average cost of GBX 2,859 per share, with a total value of £142.95.
- On Wednesday, June 10th, Steve Foots purchased 5 shares of Croda International stock. The shares were purchased at an average price of GBX 2,965 per share, for a total transaction of £148.25.
Croda International Stock Up 0.5%
CRDA opened at GBX 3,285 on Friday. The company has a debt-to-equity ratio of 36.06, a quick ratio of 2.25 and a current ratio of 2.57. The company has a market capitalization of £4.58 billion, a PE ratio of 57.73, a P/E/G ratio of 1.40 and a beta of 0.92. The stock’s fifty day moving average is GBX 3,060.22 and its 200-day moving average is GBX 2,946.12. Croda International Plc has a one year low of GBX 2,437 and a one year high of GBX 3,352.
Wall Street Analysts Forecast Growth
CRDA has been the subject of several research reports. Berenberg Bank restated a “buy” rating and set a GBX 3,600 price objective on shares of Croda International in a research report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a GBX 3,300 target price on shares of Croda International in a report on Wednesday, July 29th. Citigroup increased their target price on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Finally, Jefferies Financial Group restated a “buy” rating and set a GBX 3,500 target price on shares of Croda International in a report on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,390.
Check Out Our Latest Stock Analysis on CRDA
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Featured Articles
- Five stocks we like better than Croda International
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
